STOCK TITAN

Indivior to Participate in Upcoming Investor Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Indivior (NASDAQ: INDV) announced its participation in two upcoming investor conferences in New York City. At the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8th, CEO Joe Ciaffoni and CFO Ryan Preblick will host meetings and participate in a fireside chat at 9:15 a.m. ET. The following day, September 9th, the executives will attend the H.C. Wainwright 27th Annual Global Investment Conference for one-on-one and group meetings.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+2.85% News Effect

On the day this news was published, INDV gained 2.85%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

RICHMOND, Va., Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events:

  • Morgan Stanley 23rd Annual Global Healthcare Conference – New York City, NY

    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Monday, September 8th. Joe Ciaffoni will also participate in a fireside discussion on Monday, September 8th at 9:15 a.m. U.S. ET. Interested investors should contact their Morgan Stanley representative to schedule a meeting. The fireside discussion will be publicly available and can be viewed using the following weblink: Morgan Stanley Webcast Link
  • H.C. Wainwright 27th Annual Global Investment Conference – New York City, NY

    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, September 9th. Interested investors should contact their H.C. Wainwright representative to schedule a meeting.

About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-upcoming-investor-events-302534769.html

SOURCE Indivior

FAQ

When is Indivior's (INDV) presentation at the Morgan Stanley Healthcare Conference 2025?

Indivior's CEO Joe Ciaffoni will participate in a fireside discussion on Monday, September 8th, 2025 at 9:15 a.m. ET.

How can investors attend Indivior's meetings at the H.C. Wainwright Conference 2025?

Interested investors should contact their H.C. Wainwright representative to schedule one-on-one or group meetings with management on September 9th.

Who will represent Indivior at the upcoming investor conferences?

CEO Joe Ciaffoni and CFO Ryan Preblick will represent Indivior at both the Morgan Stanley and H.C. Wainwright conferences.

How can investors access Indivior's Morgan Stanley conference presentation?

The fireside discussion will be publicly available via webcast through the Morgan Stanley Webcast Link.
Indivior

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

4.52B
120.03M
3.88%
88.1%
6.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE